Pfizer Inc, has released promising top-line data for its Abrysvo vaccine, demonstrating high efficacy against respiratory syncytial virus (RSV) in adults aged 60 and older. These findings from the Phase 3 clinical trial hold significant implications for infection control personnel working to combat RSV infections, especially in vulnerable populations.
Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
Matthew Pullen, MD, explains rare infectious diseases, including Nipah, Scarlet Fever, Blastomycosis, and Dengue, that should be on the radar of every healthcare worker despite their rarity in the US.
A recent commentary by Dr. Amesh Adalja in MedPage Today challenges the perception of COVID-19 as solely a respiratory virus, highlighting its broader impact on the body. This analysis questions the notion that COVID-19 should be managed like common respiratory infections, urging a closer look at vaccine effectiveness, the rise of long COVID, and the need for enhanced measures to curb the virus's spread. Let's explore the complexities of COVID-19 management and the pressing realities faced by the US and the world.
The 20 conditions, known as neglected tropical diseases (NTDs), are estimated to affect more than 1 billion people, yet many individuals have never heard of them. Heather Saunders, MPH, RN, CIC, discusses 5 of them and what is being done to prevent their spread.
Lassa fever causes 5000 deaths a year. What should health care workers and the public know about this rare disease, and what is done to treat it?
Enmetazobactam (Exblifep; Orchid Pharma) has received FDA approval for treating complicated urinary tract infections (cUTIs), offering a promising solution in the battle against antimicrobial resistance.
Despite the severity of a measles diagnosis, outbreaks continue. Health care workers should encourage their patients to receive the vaccine and explain its safety.
Dive into the intricate world of malaria, from parasite complexities to climate change, and the latest in vaccination, vital knowledge for health care workers.
Health care workers urged to review biosecurity as USDA confirms first HPAI case since 2022 in domestic birds during ongoing outbreak.
Water, essential in health care, from hygiene to medical procedures. AAMI's ST108 sets new standards, vital for patient safety and equipment integrity.
Preventable health care-associated infections (pHAIs) cost US health care facilities up to $123 million per day.
The field of health care has placed a great emphasis on infection prevention in recent years, making it imperative for professionals in this domain to obtain certifications and additional training. These credentials verify their expertise and enable them to gain access to better job prospects and higher earning potential.
Automation of probe reprocessing can have multiple benefits for patients, clinicians and facilities, including improvements in efficiency, accuracy, compliance, standardization and safety. When considering process options for high level disinfection of ultrasound probes, automated systems can be an efficient and cost-effective way to prevent patients from the risk of infection. It’s time to work smarter, safer, happier, more efficiently, and accurately… not harder.
The journey of pregnancy begins long before conception, with a woman's lifestyle choices profoundly influencing her future child's health. From diet to infection prevention, proactive measures are crucial.
Eric D. Donnenfeld, MD, discusses 3 uncommon yet highly infectious eye diseases, emphasizing the importance of timely treatment and preventative measures.
Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending February 17, 2024.
The first death from Alaskapox virus (AKPV) raises alarm in Alaska, prompting expanded surveillance efforts statewide to understand and prevent potential infections.
Health care workers must stay vigilant against rare pathogens. Saskia v. Popescu, PhD, MPH, MA, FAPIC, an expert in infection prevention, emphasizes the importance of robust measures and preparedness.
VR training is a game-changer in PPE skills for health care amidst COVID-19. Study shows superiority over traditional methods, revolutionizing safety education, according to a study published today.
Stephanie Alice Baker, PhD, delves into the surge of antivaccine influencers during COVID-19, highlighting their impact on vaccine hesitancy and misinformation.
A senior microbiologist gives audiences of sister brands, Infection Control Today and Contagion, an insight into leishmaniasis, a potentially fatal disease.
Syphilis cases surge, sparking concerns. Deborah Sesok-Pizzini, MD, discusses what infection prevention and control personnel should know about testing evolution, prevention strategies, and innovations combating spread.
Gain invaluable insights on merging personal and professional growth with the APIC Competency Model, presented by the upcoming president of the Greater Los Angeles APIC Chapter, focusing on her PROACTIVE approach for infection preventionists.
Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending February 11, 2024.
Discover insights from Cindy Gaines on health care challenges, including rising costs, workforce shortages, and perioperative care transformation in 2024.
A new study examines how monitoring and reducing operating room traffic can significantly lower the risk of surgical site infections, enhancing patient safety and infection prevention protocols.
Learn about FendX Technologies' breakthrough nanotechnology, including REPELWRAP film and a spray formulation, designed to prevent the spread of infectious diseases on various surfaces.
Tina Platania discusses the significance of continuous glucose monitors (CGM) in diabetes care, highlighting CCS's individualized approach based on medical necessity. From carefully considering patient needs to collaborating with providers and payers, CCS ensures a highly personalized treatment plan, reflecting their commitment to improving overall health.
Boehringer Ingelheim and Eli Lilly's "It Takes 2" campaign, featuring a remix by hip-hop artist Rob Base, promotes early diagnosis and testing for chronic kidney disease, aiming to reduce complications, including infections.
